AQST

AQST: earnings, filings and news, read by Graham as they come out.

Reads

• Aquestive Therapeutics announced the FDA accepted its resubmission for Anaphylm and set a PDUFA goal date of March 16, 2027, following a previous Complete Response Letter. Dodd · AQST